top of page

Biocomputing: The Future of AI with Fred Jordan

Updated: 1 day ago

Discover biocomputing, an emerging field poised to revolutionize AI. Learn about its potential, challenges, and ethical considerations

What Is This About?

Fred Jordan explains how biocomputing represents the next frontier of AI — using biological systems rather than silicon chips to process information. This deep dive explores the science, the startups, and the timeline for when biological computers could complement or replace traditional computing.

Introduction

Fred Jordan explores the frontier where biology meets computing — a field that could fundamentally change how we process information. This extensive interview covers biocomputing's potential to complement and eventually surpass silicon-based chips for specific AI workloads, examining the science, the startup opportunities, and the timeline for biological computing systems to move from laboratory demonstrations to commercial applications.

Executive Summary

Fred Jordan explores biocomputing's potential to complement and eventually surpass silicon-based chips for specific AI workloads by using biological processes for computation. The technology leverages DNA, proteins, and cellular machinery to perform parallel processing at energy efficiency levels impossible with conventional semiconductors. Current applications remain at the laboratory demonstration stage, with commercial viability estimated at 5-10 years for initial use cases. The interview covers the science, startup opportunities, and the realistic timeline for biological computing to move from research to commercial deployment.

Key Takeaways

Atomic Answer

What Is This About?

Fred Jordan explains how biocomputing represents the next frontier of AI — using biological systems rather than silicon chips to process information. This deep dive explores the science, the startups, and the timeline for when biological computers could complement or replace traditional computing.


Fred Jordan, CEO of Final Spark, discusses the future of AI with biocomputing


In this episode of Startuprad.io, host Jörn "Joe" Menninger sits down with the founder of Biocomputing to explore how this DACH-based startup is tackling real market challenges. From early-stage hustle to scaling strategy, this founder interview dives deep into what it takes to build a startup in the German-speaking ecosystem.

This founder interview is part of our ongoing coverage of Scaleup Founder Interviews from Germany, Austria, and Switzerland.


Imagine a world where computers run on biological matter, consuming a fraction of the energy of today's silicon-based systems. This is the promise of biocomputing, an emerging field poised to revolutionize artificial intelligence (AI) and computing as we know it. In this episode of Startuprad.io, Joe Menninger sits down with Fred Jordan, the CEO and co-founder of FinalSpark, a pioneering company in the world of biocomputing.


What is Biocomputing?

Biocomputing utilizes biological molecules, such as neurons, to perform computations.  This approach offers a radical departure from traditional silicon-based computing, with the potential to dramatically reduce energy consumption and unlock new levels of efficiency in AI applications.    


Our Sponsor Vanta

Vanta automates security and compliance for frameworks like ISO 27001, SOC 2, and more—so you’re always audit-ready without the stress and manual work. No more endless spreadsheets, no last-minute panic. With real-time monitoring and automated security questionnaires, Vanta saves you time, effort, and money—so you can focus on growing your business.


Over 9,000 companies, including Atlassian, Flo Health, and Quora, already trust Vanta to manage security seamlessly.


Make compliance simple—get $1,000 off now at vanta.com/startupradio.


The Potential of Biocomputing

  • Energy Efficiency: Biocomputing could significantly reduce the energy footprint of AI, addressing a growing concern as AI applications become more prevalent.    

  • Enhanced Performance: By utilizing the inherent complexity and adaptability of biological systems, biocomputing could enable more efficient and sophisticated AI models.    

  • New Applications: Biocomputing could open doors to entirely new applications, such as human augmentation, advanced biosensors, and even hybrid objects that integrate living and non-living components.    


How Does Biocomputing Work at Final Spark?

Final Spark's approach involves creating "brain organoids," small balls of interconnected neurons that are placed on electrodes to send and receive information.  These organoids are grown from human-derived stem cells, offering a potentially scalable and cost-effective way to produce biocomputing components.    


The Challenges of Biocomputing

  • Technical Hurdles: One of the main challenges lies in "teaching" these biological systems to perform specific computations reliably and efficiently.    

  • Ethical Considerations: The use of human-derived neurons raises ethical questions that require careful consideration and collaboration with experts in the field.    


The Future of Biocomputing

Despite the challenges, the future of biocomputing looks bright. Fred Jordan envisions a future where biocomputers work alongside traditional computers, powering cloud computing services and enabling AI applications with unprecedented efficiency and capabilities.    


Final Spark and the Biocomputing Revolution

Final Spark is at the forefront of this revolution, pushing the boundaries of biocomputing research and development.  With ambitious plans to create a biocomputer server within the next 12 to 13 years, Final Spark is paving the way for a future where biocomputing becomes an integral part of our technological landscape.    


Get Involved in Biocomputing

The field of biocomputing is ripe with opportunities for researchers, investors, and anyone passionate about shaping the future of AI. Final Spark is actively seeking talent and funding to accelerate its research and development efforts.    


Conclusion

Biocomputing is a fascinating and rapidly evolving field with the potential to transform the world of AI and beyond. As Fred Jordan eloquently puts it, "Biocomputing is not just a simple new technology. It's a new industry that is going to stay and change everything in the coming 10 to 20 years."    


Leave a review, share and comment on the episode!


All rights reserved - Startuprad.io™


Find More Deep Tech and AI


If you are looking to understand the rise of AI and deep tech startups in Europe, including how emerging technologies like machine learning, quantum computing, and robotics are transforming industries, you should not miss Europe’s Ultimate Guide to AI & Deep Tech Startups. This in-depth resource provides founders, investors, and ecosystem leaders with a comprehensive overview of European AI innovation, venture capital trends, and deep tech opportunities, making it a must-read for anyone aiming to stay ahead in the fast-growing European startup landscape.


Learn More

Relationship Map

  • Jörn "Joe" Menninger → Host of → Startuprad.io

Frequently Asked Questions

What is this article about: Biocomputing: The Future of AI with Fred Jordan?

Discover biocomputing, an emerging field poised to revolutionize AI. Learn about its potential, challenges, and ethical considerations

What are the main takeaways from this discussion?

Fred Jordan explains how biocomputing represents the next frontier of AI — using biological systems rather than silicon chips to process information. This deep dive explores the science, the startups, and the timeline for when biological computers could complement or replace traditional computing.

How does this topic connect to the broader startup ecosystem?

Fred Jordan explores the frontier where biology meets computing — a field that could fundamentally change how we process information. This extensive interview covers biocomputing's potential to complement and eventually surpass silicon-based chips for specific AI workloads, examining the science, the startup opportunities, and the timeline for biological computing systems to move from laboratory demonstrations to commercial applications.

Access Europe's Startup and Technology Decision Makers

This article is part of Startuprad.io's structured coverage of the European startup ecosystem, with deep editorial roots in Germany, Austria, and Switzerland. The platform reaches a highly targeted audience of founders, operators, and investors — over 90% of whom are based in Europe. Companies partner with Startuprad.io to gain visibility within this ecosystem and build credibility where business decisions are made. Explore partnership opportunities.

About the Host

Joern "Joe" Menninger is the host of the Startuprad.io podcast and covers founders, investors, and policy developments across the DACH startup ecosystem. Through more than 1,300 interviews and nearly a decade of reporting, he documents the evolution of the European startup landscape. Follow Joern on LinkedIn.

Comments


Become a Sponsor!

...
Sign up for our newsletter!

Get notified about updates and be the first to get early access to new episodes.

Affiliate Links:

...
bottom of page